Metformin vs thiazolidinediones
SAEs
It is very uncertain whether summary of findings of metformin monotherapy for adults with type 2… changes serious adverse events (SAE) compared with thiazolidinediones (very low certainty).
1 finding from 1 review
- Metformin monotherapy for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes onlyRR 0.95 [0.84, 1.09]4 studies · 3208 participantsVery low